Business Description
Landfar Bio-medicine Co Ltd
NAICS : 511120
ISIN : CNE000000263
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 12.91 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -0.45 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 4.41 | |||||
Beneish M-Score | -3.15 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.2 | |||||
3-Year Book Growth Rate | 109.3 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 73.99 | |||||
9-Day RSI | 58.7 | |||||
14-Day RSI | 51.35 | |||||
6-1 Month Momentum % | 52.77 | |||||
12-1 Month Momentum % | -5.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.83 | |||||
Quick Ratio | 1.76 | |||||
Cash Ratio | 1.17 | |||||
Days Inventory | 131.82 | |||||
Days Sales Outstanding | 389.41 | |||||
Days Payable | 736.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.9 | |||||
Shareholder Yield % | 1.55 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 68.78 | |||||
Operating Margin % | -8.51 | |||||
Net Margin % | -29.79 | |||||
FCF Margin % | 7.19 | |||||
ROE % | -18.13 | |||||
ROA % | -5.98 | |||||
ROIC % | -3.6 | |||||
3-Year ROIIC % | -21.83 | |||||
ROC (Joel Greenblatt) % | -202.47 | |||||
ROCE % | -19.85 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 25.09 | |||||
PB Ratio | 12.15 | |||||
Price-to-Tangible-Book | 12.15 | |||||
Price-to-Free-Cash-Flow | 376.38 | |||||
Price-to-Operating-Cash-Flow | 140.45 | |||||
EV-to-EBIT | -49.59 | |||||
EV-to-EBITDA | -49.59 | |||||
EV-to-Revenue | 21.63 | |||||
EV-to-FCF | 264.52 | |||||
Price-to-Projected-FCF | 12.15 | |||||
Price-to-Median-PS-Value | 0.72 | |||||
Price-to-Net-Current-Asset-Value | 20.24 | |||||
Earnings Yield (Greenblatt) % | -2.02 | |||||
FCF Yield % | 0.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Landfar Bio-medicine Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 124.448 | ||
EPS (TTM) (Â¥) | -0.117 | ||
Beta | 1.06 | ||
Volatility % | 51.6 | ||
14-Day RSI | 51.35 | ||
14-Day ATR (Â¥) | 0.473803 | ||
20-Day SMA (Â¥) | 8.5325 | ||
12-1 Month Momentum % | -5.03 | ||
52-Week Range (Â¥) | 5.26 - 11.39 | ||
Shares Outstanding (Mil) | 330.02 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Landfar Bio-medicine Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Landfar Bio-medicine Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Landfar Bio-medicine Co Ltd Frequently Asked Questions
What is Landfar Bio-medicine Co Ltd(SZSE:000504)'s stock price today?
When is next earnings date of Landfar Bio-medicine Co Ltd(SZSE:000504)?
Does Landfar Bio-medicine Co Ltd(SZSE:000504) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |